ArticleBMJ nutrition, prevention & health2025
Unrecognised rural-urban disparities in epidemiology of metabolic-associated fatty liver disease in the representative area of China.
Article in BMJ nutrition, prevention & health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- [Construction norms for the tiered diagnosis and treatment and standardized management center of metabolic-associated fatty liver disease].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2026Guideline
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The unexpectedly increased burden of metabolic-associated fatty liver disease (MAFLD) continues in China, and the differences between rural and urban areas remain unclear. We aimed to clarify the prevalence and risk factors in rural areas of China. Methods: This cross-sectional study used the most densely populated area with highly unbalanced development differences in China (Guangdong Province) as a representative sample, and multistage stratified random sampling was performed. The participants' demographic, socioeconomic and lifestyle data were collected. Fatty liver and liver stiffness were screened by FibroScan. Results: A total of 7287 individuals were enrolled (rural: 2684; urban: 4603). The overall MAFLD prevalence was 35.7%, and MAFLD was higher among rural individuals (38.0% vs 34.4%, p<0.001) than urban individuals. Rural individuals had more severe hepatic fibrosis (fibrosis stage 3-4) overall (3.0% vs 1.3%) and among different sexes (male: 4.2% vs 2.0%; female: 1.5% vs 0.5%) (all p<0.05) than urban individuals. For both rural and urban individuals, lifestyle and dietary habits, including midnight snacks, dining out, and overeating salt, red meat and sugar, were associated with an increased risk of MAFLD, and drinking tea and consuming dietary fibres were associated with a decreased risk of MAFLD. However, midnight snacks and overeating red meat were associated with a higher risk of hepatic fibrosis only in urban individuals. Conclusion: There is a surprisingly high burden of MAFLD in rural Guangdong, China, which implicates a lack of awareness among rural individuals and a warrant the need for disease counteraction strategies. Trial registration number: ChiCTR2000033376.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.